Dr. Reddy’s Laboratories Ltd - Potential Investments & Pipelines to Unlock Value
Reported revenue grew by 16.5% YoY, driven by strong growth in the North America business (18% YoY) and India business (18% YoY). The Europe...
259 Views
Pharma and Healthcare (Q2FY25E Results Preview): Steady Q2, Revlimid to Normalise
The India Pharma & Healthcare sector is expected to maintain its growth momentum in Q2FY25E. We project sales/EBITDA growth of 11%/15% YoY for our...
324 Views
HSIE Results Daily: ICICI Bank, Dr Reddy’s Laboratories, Ashok Leyland
ICICI Bank: ICICI Bank (ICICIBC) clocked a mild beat on the back of steady margins (-4bps QoQ) and better operating efficiency (higher non-core...
334 Views
Pharma and Healthcare (Q1FY25E Results Preview): Start the Year on a Strong Nod
The India Pharma & Healthcare sector is expected to maintain the growth momentum in Q1FY25E. We expect our coverage universe to see 11%/13% YoY...
322 Views
Dr Reddy’s Laboratories: To Acquire Global OTC Portfolio for Ex-US Market.
Dr Reddy’s (DRRD) is going to acquire Haleon’s global portfolio of consumer healthcare brands (Northstar Switzerland) in the Nicotine Replacement...
313 Views